Vaxcyte shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Vaxcyte (PCVX) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Vaxcyte
Tip: Access up to 7 years of quarterly data
All positions including Vaxcyte held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Vaxcyte by MetLife Investment Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $7.8M | 68k | 114.27 |
2024-06-30 | $4.8M | 63k | 75.51 |
2023-12-31 | $3.1M | 49k | 62.80 |
2023-09-30 | $2.5M | 49k | 50.98 |
2023-06-30 | $2.4M | 48k | 49.94 |
2023-03-31 | $1.4M | 38k | 37.48 |
2022-12-31 | $1.8M | 38k | 47.95 |
2022-09-30 | $661k | 28k | 24.00 |
2022-06-30 | $599k | 28k | 21.76 |
2022-03-31 | $572k | 24k | 24.15 |
2021-12-31 | $356k | 15k | 23.79 |
2021-09-30 | $379k | 15k | 25.36 |
2021-06-30 | $336k | 15k | 22.48 |
2021-03-31 | $231k | 12k | 19.73 |
2020-12-31 | $209k | 7.9k | 26.58 |
2020-09-30 | $388k | 7.9k | 49.38 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors